ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

GenusPlus posts record H2 2026 profit, shares dip on guidance

The infrastructure services group posted AUD 1.28 billion in revenue and AUD 54 million in net profit for the half year, but its stock fell after FY2027 EBITDA guidance came in below some analyst expectations.

PA
Priya Anand · Equities & Earnings Desk · 25 Aug 2026 · 07:02 · 2 min read
Share
GenusPlus posts record H2 2026 profit, shares dip on guidance

GenusPlus Ltd reported a record first-half result for 2026, with revenue rising 70% year-over-year to AUD 1.28 billion and underlying net profit after tax reaching AUD 54 million. The infrastructure and services group also posted its first EBITDA above AUD 100 million, while free cash flow before tax climbed 66% to AUD 229 million.

The company’s cash balance stood at AUD 315 million at period-end, including AUD 195 million from an equity raise tied to the acquisition of MPK. Gross profit margin remained robust at 75.77%, while recurring revenue totaled AUD 764 million. The infrastructure division, which includes large-scale transmission and renewable energy projects such as HumeLink East and North West Transmission Developments, generated AUD 837 million in revenue, up 100% from the prior year. The services division contributed AUD 150 million.

GenusPlus increased its debt facility from AUD 260 million to AUD 549 million and issued AUD 240 million in bank guarantees and surety bonds as of June 30. Group EBITDA margins were maintained above 6%, within the company’s target range of 4% to 8%. Capital expenditure for the period totaled AUD 44 million.

For the 2027 financial year, management guided EBITDA to AUD 200 million to AUD 205 million, driven by organic growth, contributions from MPK and Railtrain, and an expanded employee base of approximately 3,400 following the MPK acquisition. Capital expenditure is expected to range between AUD 65 million and AUD 70 million, primarily for long-lead transmission and critical-path equipment. The group’s order book stands at AUD 2.2 billion, with a tender pipeline of AUD 3.6 billion.

Shares in GenusPlus fell 1.79% to AUD 8.77 after the results, paring a 92% gain over the past year. The stock has traded between AUD 4.55 and AUD 11.35 over the last 52 weeks, with a beta of 0.63.

CEO David highlighted the company’s achievement of surpassing AUD 100 million in EBITDA for the first time, while CFO Damian noted that statutory profit reflects all acquisition-related costs.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT